Skip to content
LineaRx, Inc. Signs Licensing Agreement with LifeSensors
January 13, 2020
Read More email
APDN Reports 14 Development Customers for its Linear DNA Manufacturing Platform
November 25, 2019
Read More email
iCTC Platform Shows Superior Correlation over PSA as a Biomarker
October 1, 2019
Read More email
Medicare Coverage of CAR T-Cell Therapy Holds Positive Implications for LineaRx
August 12, 2019
Read More email
LineaRx Acquires Assets and Intellectual Property of Vitatex
August 8, 2019
Read More email
LineaRx Receives Multiple Orders for Linear DNA for Use in Therapeutic Development
July 1, 2019
Read More email
LineaRx Anticipates Expansion in Diagnostics Market
May 21, 2019
Read More email
LineaRx Achieves Higher Expression and Survival Rates in Human T Cells
April 29, 2019
Read More email
LineaRx Achieves Anti-CD19 Expression in Human CAR T Cells via Plasmid-Free Platform
April 8, 2019
Read More email
LineaRx to Announce DNA Vaccine Preclinical Data and Efficacy of In-Licensed CAR T Therapy
December 4, 2018
Read More email
LineaRx Provides Cost and Quality Advantages to Technogenetics
November 7, 2018
Read More email
At LineaRX, Putting The Horsepower Behind The CAR T
October 17, 2018
Read More email
LineaRx Licenses CAR T Drug Candidate, Initiates Pre-Clinical Development of Non-viral, Plasmid-free CAR T Manufacturing Platform
October 16, 2018
Read More email
LineaRx Secures New RNA Therapeutics Customers for Contract Research Services
October 1, 2018
Read More email
With New Spinoff, Biotech Goes All-In On DNA Sales
September 19, 2018
Read More email
APDN Forms Subsidiary, LineaRx, to Develop DNA for Biotherapeutics
September 18, 2018
Read More email
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. Ok 
